U.N.'s errant prescription for drug access

What's the best way to improve health care for billions of people in the developing world? If you answered, “Attack health care firms,” you qualify for a job with the United Nations.

You'd also be dead wrong.

The U.N. recently released a plan to severely weaken patent protections and other forms of intellectual property (IP). U.N. officials believe that this will bring down the price of medicine in the developing world, thereby improving people's access to drugs.

Their recommendations would do the exact opposite. Dissolving IP protections would disincentivize drug research and slow the discovery of new treatments. Patients in both the developing and developed worlds would be worse off.

Drug development is an enormously expensive endeavor. It costs, on average, $2.6 billion to bring a new medicine to market. Just one out of every 5,000 promising compounds makes it from the lab through clinical trials to the pharmacy shelf. And just two out of every 10 approved drugs ever turn a profit.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Dr. Scott Gottlieb is the right man in the right place at the right time....  Read more

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

CMPI President Peter Pitts appears on NY1 News to discuss Governor Cuomo's prescription drug proposal...  Read more

How Other Countries Freeload on U.S. Drug Research

How Other Countries Freeload on U.S. Drug Research

Letting Americans buy prescriptions from foreign retailers would impair the development of new cures....  Read more

DRUGWONKS BLOG